Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae

Background: Carbapenemase-producing Klebsiella pneumoniae and Escherichia coli have become a significant global health challenge. This has created an urgent need for new treatment modalities. We evaluated the efficacy of mecillinam in combination with either avibactam or ceftazidime/avibactam agains...

Descripción completa

Detalles Bibliográficos
Autores principales: List, Karoline Knudsen, Kolpen, Mette, Kragh, Kasper Nørskov, Charbon, Godefroid, Radmer, Stine, Hansen, Frank, Løbner-Olesen, Anders, Frimodt-Møller, Niels, Hertz, Frederik Boetius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599007/
https://www.ncbi.nlm.nih.gov/pubmed/36289937
http://dx.doi.org/10.3390/antibiotics11101280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599007/
https://www.ncbi.nlm.nih.gov/pubmed/36289937
http://dx.doi.org/10.3390/antibiotics11101280

Ejemplares similares